Global Oral Transmucosal Drugs Market is valued at approximately USD 34.37 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.71% over the forecast period 2024-2032.
Life expectancy for people with sickle cell in the U.S. has increased to about 50 years, but some people with the disease still face stigma and other barriers in health care ...